Clinical Trials Logo

Cigarette Smoker clinical trials

View clinical trials related to Cigarette Smoker.

Filter by:
  • Recruiting  
  • Page 1

NCT ID: NCT03865472 Recruiting - Cigarette Smoker Clinical Trials

rTMS in Promoting Smoking Cessation and Preventing Relapse in Current Smokers

Start date: November 10, 2018
Phase: N/A
Study type: Interventional

This trial studies best dose and how well repetitive transcranial magnetic stimulation (rTMS) works in promoting smoking cessation and preventing relapse in current smokers. rTMS is a form of brain stimulation therapy that controls nerve cell activity, increases blood flow in the brain, and improves cognitive function.

NCT ID: NCT03824535 Recruiting - Clinical trials for Multiple Pulmonary Nodules

18F-FSPG PET/CT in Diagnosing Early Lung Cancer in Patients With Lung Nodules

Start date: February 4, 2019
Phase: Phase 2
Study type: Interventional

This phase II trial studies how well 18F-FSPG positron emission tomography (PET)/computed tomography (CT) work in diagnosing early lung cancer in patients with lung nodules. PET imaging with an imaging agent called 18F-FDG is often used in combination with a PET/CT scanner to evaluate cancers. Giving 18F-FSPG before a PET/CT scan may work better in helping researchers diagnose early lung cancer in patients with lung nodules.

NCT ID: NCT03691350 Recruiting - Cigarette Smoker Clinical Trials

Bronchoscopy in Determining the Effect of E-Cigarette Smoking on Biomarkers in the Lungs

Start date: September 17, 2018
Phase: Early Phase 1
Study type: Interventional

This trial studies biomarkers obtained by bronchoscopy (bronchoalveolar lavage and lung brushings) to determine the effect of smoking e-cigarettes on the lungs. Studying samples of lung cells from participants who smoke e-cigarettes may help doctors learn more about changes that occur in deoxyribonucleic acid and identify biomarkers related to cancer.

NCT ID: NCT03199651 Recruiting - Clinical trials for Stage IV Non-Small Cell Lung Cancer

Beating Lung Cancer in Ohio Protocol in Improving Survival in Patients With Stage IV Non-Small Cell Lung Cancer

BLCIO
Start date: July 17, 2017
Phase: N/A
Study type: Interventional

This randomized clinical trial studies the Beating Lung Cancer in Ohio protocol in improving survival in patients with stage IV non-small cell lung cancer. The Beating Lung Cancer in Ohio protocol may help in evaluating immunotherapies and targeted therapies that prolong survival, have more favorable toxicity profiles than conventional chemotherapy and impact quality of life.